Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. Developed by Fujirebio, the Lumipulse G test measures ...
Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detectâ„¢ product line for assessing symptomatic patients SECAUCUS, N.J., July 9, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback